EIMID · European Initiative for Basic Research in Microbiology and Infectious Diseases
FP6 — Marie Curie Actions (Human Resources and Mobility)
- Duration
- 2006-03-01 → 2010-02-28
- EU contribution
- €1,815,762
- Participants
- 7
- Scheme
- EST
Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.
Project objective
By initially building a strong coalition among five European centres of excellence, the objectives of EIMID are to reach a critical mass on relevant microbiology topics; to allow rapid and effective scientific reaction to emerging problems; to foster exchange of scientists; to improve the visibility of Microbiology and Infectious Diseases as a discipline of key importance in Europe; to attract the best fellows and post-docs to the area; to counter the current brain drain of young European investigators to USA. In this context, a consortium will come together, composed of the small Italian company ALTA, the Max Planck Institute for Infection Biology in Berlin, the Centre for Molecular Microbiology and Infection at Imperial College London, the Institut Pasteur in Paris, the Karolinska Institutet in Stockholm, and the vaccine company Chiron in Siena. The consortium will organise a 3-year PhD training programme for fellows who will visit different EIMID centres. Interdisciplinarity and academic-industrial cooperation will be emphasized. Ten fellows will follow an individual training pathway in the areas of host-pathogen interaction and novel strategies for designing vaccines and inhibitors. Parallel training aimed at improving complementary skills will implement the fellows' future role in the global scientific world.
Original text from CORDIS.
Participants
- ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE S.R.L. · SIENACoordinatorCity levelItaly
- CHIRON S.R.L. · SIENAItaly
- IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · LONDONUnited Kingdom
- INSTITUT PASTEUR · PARISFrance
- KAROLINSKA INSTITUTET · STOCKHOLMSweden
- MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. · MUENCHENGermany
- NOVARTIS VACCINES AND DIAGNOSTICS SRL · SIENAItaly
Links
Data: CORDIS, © European Union